PubRank

M C Rowbotham

Author PubWeight™ 31.36‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology 2007 2.55
2 Pilot clinical trial of gabapentin to decrease postoperative delirium in older patients. Neurology 2006 1.97
3 Neurologic aspects of cocaine abuse. West J Med 1988 1.71
4 What is a "clinically meaningful" reduction in pain? Pain 2001 1.57
5 Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 1999 1.45
6 A new human experimental pain model: the heat/capsaicin sensitization model. Neuroreport 1999 1.26
7 Capsaicin evoked pain and allodynia in post-herpetic neuralgia. Pain 2000 1.18
8 The effect of systemic lidocaine on pain and secondary hyperalgesia associated with the heat/capsaicin sensitization model in healthy volunteers. Anesth Analg 2000 1.14
9 Effect of remifentanil on pain and secondary hyperalgesia associated with the heat--capsaicin sensitization model in healthy volunteers. Anesthesiology 2001 1.08
10 Acute neurologic and psychiatric complications associated with cocaine abuse. Am J Med 1987 0.99
11 Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: a prospective study. J Pain Symptom Manage 1996 0.95
12 Effect of intravenous magnesium on pain and secondary hyperalgesia associated with the heat/capsaicin sensitization model in healthy volunteers. Br J Anaesth 2001 0.94
13 Neuropathic pain needs systematic classification. Eur J Pain 2013 0.93
14 Response to intravenous lidocaine infusion differs based on clinical diagnosis and site of nervous system injury. Neurology 1993 0.90
15 Effect of adrenergic receptor activation on post-herpetic neuralgia pain and sensory disturbances. Pain 1997 0.90
16 Pain caused by herpes zoster infection. Neurol Clin 1998 0.89
17 Effect of systemic adenosine on pain and secondary hyperalgesia associated with the heat/capsaicin sensitization model in healthy volunteers. Reg Anesth Pain Med 2001 0.89
18 Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences. Pain 2009 0.86
19 A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain. Neurology 2002 0.83
20 Lack of efficacy of riluzole in the treatment of peripheral neuropathic pain conditions. Neurology 2000 0.83
21 Trazodone-oral cocaine interactions. Arch Gen Psychiatry 1984 0.83
22 Thalamomesencephalic strokes after cocaine abuse. Neurology 1989 0.82
23 The interpretation of pain relief and sensory changes following sympathetic blockade. Brain 1994 0.81
24 Effect of EMLA pre-treatment on capsaicin-induced burning and hyperalgesia. Acta Derm Venereol 1999 0.81
25 Will ion-channel blockers be useful for management of nonneuropathic pain? J Pain 2000 0.79
26 Cocaine, nicotine, caffeine, and metabolite plasma concentrations in neonates. J Anal Toxicol 1998 0.79
27 Venlafaxine hydrochloride and chronic pain. West J Med 1996 0.78
28 Failure of naloxone to reverse apomorphine effects in humans. Psychoneuroendocrinology 1983 0.77
29 Complex regional pain syndrome type I (reflex sympathetic dystrophy): more than a myth. Neurology 1998 0.76
30 Cocaine metabolite kinetics in the newborn. J Anal Toxicol 1999 0.76
31 Herpes zoster. N Engl J Med 2000 0.75
32 Treatment of inflammatory, neuropathic and sympathetically maintained pain in a patient with Sjögren's syndrome. Pain 1992 0.75
33 Quantitation of levorphanol in human plasma at subnanogram per milliliter levels using capillary gas chromatography with electron-capture detection. J Chromatogr B Biomed Sci Appl 1999 0.75